Antibiotic Medication - Search News

Viridian confirms benefit of drug for thyroid eye disease

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Fighting back a hyper

Reuters on MSN · 41m

Viridian shares soar after latest trial success for thyroid eye disease drug

Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage study, sending its shares surging more than 26%.

Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.

Drug company: We won’t charge more for ‘green’ inhalers

The news followed an investigation by POLITICO's E&E News into climate-friendly inhalers and how drug giants are developing ...

New RSV drug for babies is over 90% effective at preventing hospitalization

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results